Columbus, OH, United States of America

Robert C Tuttle

This inventor holds 1 USPTO granted patent. Top assignee: Embrex, Inc.. Active years: 2006.


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Robert C. Tuttle

Introduction

Robert C. Tuttle is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of protozoan purification. His work focuses on developing methods that enhance the efficiency of purifying oocysts, which are critical in various biological and medical applications.

Latest Patents

Tuttle holds a patent for a method of purifying oocysts using enzymatic digestion of fecal debris. This invention provides methods and compositions for purifying protozoan oocysts. In particular embodiments, the oocysts are treated with polysaccharidase under conditions sufficient to reduce the amount of fecal material in the composition. This innovative approach has the potential to improve the quality and safety of biological samples.

Career Highlights

Robert C. Tuttle is associated with Embrex, Inc., where he applies his expertise in the field of biological sciences. His work at the company has contributed to advancements in the purification processes that are essential for research and clinical applications. Tuttle's dedication to innovation is evident in his focused research and development efforts.

Collaborations

Tuttle has collaborated with James E. Hutchins, further enhancing the impact of his work in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving significant breakthroughs in scientific research.

Conclusion

Robert C. Tuttle's contributions to the field of protozoan purification through his patented methods highlight his role as an influential inventor. His work not only advances scientific knowledge but also has practical applications that can benefit various industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…